Soligenix Inc. (SNGX)
Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçets Disease Published in Rheumatology (Oxford)
Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçets Disease Published in Rheumatology (Oxford)
📈 **POSITIVE** • High confidence analysis (84%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business